AvantGuard is a finalist in the RESI Boston Innovator's Pitch Challenge
AvantGuard News
​​​​AvantGuard Named Semi-Finalist in 2024 Pepperdine Most Fundable Companies Competition
Dr. Carine Nkemngong's Insights on Biofilms and Pathogen Persistence in Healthcare and Food Processing
The Source Code Podcast Features AvantGuard
AvantGuard at the Forefront of Wound Care and Medical Technology
AvantGuard Selected as Hello Tomorrow Deep Tech Pioneer: Shaping the Future of Pathogen Defense
AvantGuard Leads Charge at NewYorkBIO's Mini Pitch Day
Ted Eveleth, Shares AvantGuard’s Success Story at the 2023 New York State Innovation Summit
AvantGuard Recognized as Top Key Player in the Surface Disinfectants Market by IMIR Market Research
AvantGuard’s Bright Pitch Shines at TechCrunch Disrupt 2023
AvantGuard Wants To Turn Chlorine Into the Best Antiseptic You’ve Ever Seen
Device Strategies To Prevent Healthcare-Associated Infections
AvantGuard, Inc. Set to Make Waves at TechCrunch Disrupt 2023
The Problem With Modern Disinfectants & What The Future of Infection Protection Should Look Like
$325K NIH Phase I Grant: Advancing Urinary Catheter Technology with AvantGuard